MML Investors Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
ACA
FCM
MML Investors Services's SRPT Position: Q1 2025 in Review
MML Investors Services sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 1,829 shares — an estimated $222K sold.
MML Investors Services first reported a position in SRPT in Q2 2017 and held it in 15 quarters. The position peaked at $1.35M in Q2 2024. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.
- MML Investors Services reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
- MML Investors Services sold 1,829 Sarepta Therapeutics shares in Q1 2025, an estimated $222K.
- MML Investors Services first reported a position in Sarepta Therapeutics in Q2 2017 and held it in 15 quarters.
- MML Investors Services's Sarepta Therapeutics position peaked at $1.35M in Q2 2024.
- 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.
Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.